Luis Garduño
Partner and CEO
View from the Top

Awareness Needed to Grow Manufacturing Quality

Wed, 12/05/2018 - 14:06

Q: What can Art-Técnica offer its clients that its competitors cannot?
A: We have three priorities: quality, technology and a strong ethical profile. Our solutions allow for medical equipment that delivers quality for both patients and doctors. Our people and the brands we manage — including Fluke Biomedical and Raysafe — must be oriented to offer the best possible solution in the market. At the same time, considering that the Mexican market is not that mature in terms of regulations, we strive to follow an ethical business model that makes quality our top priority, thus providing an advantage to our clients.
Q: What strategies have you implemented to showcase the advantages of brands like Fluke Biomedical and Raysafe?
A: We work in a niche market targeting biomedical engineers, which means that good references are essential to grow our business. To get these, we rely on the high quality of our product portfolio and the advanced qualifications of our personnel, all of whom are experienced enough to get any international certification available. We are certifying our personnel and processes with the Mexican Certification Entity and our goal is to become a reference in medical equipment manufacturing and the development of biomedical engineering in Mexico and Latin America, as well as an enabler of quality in the day-to-day operations of hospitals and clinics.
Our goal is to establish close relationships with quality equipment-manufacturers. Consequently, we have seen greater dynamism regarding local manufacturing, which has opened the door for Art-Técnica to offer its products as a way to ensure optimal functionality. We play a key role in helping local companies grow their competitiveness and work under international standards, which allows them to expand their client base beyond Mexico’s borders. Once they incorporate the latest technologies, they can standardize their processes to reduce production costs.
Q: How can the market become mature enough to compete with other international medical-devices hubs?
A: There needs to be greater awareness regarding the importance of quality in biomedical engineering. When manufacturers emphasize quality, standards rise accordingly. At the same time, there should be a stricter regulatory framework that forces companies to work in line with international guidelines. That would help the market take the next step toward competitiveness and specialization.
Q: Once enforced, how will USMCA impact the medical-devices sector?
A: On the one hand, the agreement will strengthen the US economy, which will lead to devaluation of the peso and higher prices, given that most pieces of equipment are priced in dollars. On the other hand, USMCA will also homologate certain manufacturing standards across the region, which will help Mexico adapt its regulations to meet international quality standards. The challenge for SMEs in the sector will be to develop their workforce’s competencies to ensure efficient results. One of our priorities is to look for forums and similar avenues that provide us the opportunity to participate in the development of standardized regulations and their implementation.
Q: What are your priorities for Art-Técnica in the near future?
A: We see the healthcare market growing in Mexico and Latin America. This will spur the participation of more project integrators and these are Art-Técnica’s targets. These players are in charge of finding the right suppliers to build and ramp up the operations of any new healthcare facility. Integrators make their decisions based on quality and price and, as managers of different brands in the biomedical engineering subsector, we can help them effectively identify the best suppliers.